Faculty of Medicine, Zagazig University, Zagazig, El-Sharkia, Egypt; Student Research Unit, Zagazig University, Zagazig, El-Sharkia, Egypt.
Department of Functional Sciences, Discipline of Pathophysiology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
J Clin Lipidol. 2017 Jul-Aug;11(4):972-985.e9. doi: 10.1016/j.jacl.2017.06.001. Epub 2017 Jun 13.
Evidence about the optimal time of day at which to administer statins is lacking.
The objective of this study is to synthesize evidence about effects of morning vs evening statin administration on lipid profile.
We searched PubMed, SCOPUS, Web of Science, and Embase databases (from inception up to July 24, 2016) to identify the relevant studies. Mean differences (MDs) between the change scores in lipid parameters were pooled using a fixed-effect model.
Eleven articles with 1034 participants were eligible for the analysis. The pooled analysis comparing effects of morning vs evening administration of statins on plasma total cholesterol (TC; P = .10), high-density lipoprotein cholesterol (P = .90), and triglycerides (P = .45) was not statistically significant. Low-density lipoprotein cholesterol (LDL-C) lowering was statistically greater in the evening-dose group (MD: 3.24 mg/dL, 95% CI: 1.23-5.25, P = .002). Subgroup analysis according to statin half-lives showed that evening dose of statins was significantly superior to morning dose for lowering LDL-C in case of both short and long half-life statins (MD: 9.68 mg/dL, 95% CI: 3.32-16.03, P = .003 and MD: 2.53 mg/dL, 95% CI: 0.41-4.64, P = .02, respectively) and also for TC reduction in case of short half-life statins only (P = .0005).
LDL-C and TC lowering was significantly greater in the evening dose than in the morning dose in case of short-acting statins. Besides slight but significant effect on LDL-C, the efficacy of long-acting statins was equivalent for both regimens. Therefore, long-acting statins should be given at a time that will best aid compliance. Short-acting statins should be given in the evening.
目前缺乏关于他汀类药物最佳给药时间的证据。
本研究旨在综合评估他汀类药物晨服与晚服对血脂谱的影响。
我们检索了 PubMed、SCOPUS、Web of Science 和 Embase 数据库(从建库至 2016 年 7 月 24 日),以确定相关研究。采用固定效应模型对脂质参数变化评分的均值差值(MD)进行合并。
纳入 11 项研究共 1034 例患者符合分析标准。比较晨服与晚服他汀类药物对血浆总胆固醇(TC;P=.10)、高密度脂蛋白胆固醇(P=.90)和三酰甘油(P=.45)影响的汇总分析结果无统计学意义。晚服组 LDL-C 降低更明显(MD:3.24mg/dL,95% CI:1.23-5.25,P=.002)。根据他汀类药物半衰期的亚组分析显示,对于半衰期短和长的他汀类药物,晚服均明显优于晨服降低 LDL-C(MD:9.68mg/dL,95% CI:3.32-16.03,P=.003 和 MD:2.53mg/dL,95% CI:0.41-4.64,P=.02),对于半衰期短的他汀类药物,还可降低 TC(P=.0005)。
对于半衰期短的他汀类药物,晚服组 LDL-C 和 TC 降低更明显。除了对 LDL-C 有轻微但显著的影响外,长效他汀类药物两种方案的疗效相当。因此,长效他汀类药物应在最有助于提高依从性的时间给药。对于半衰期短的他汀类药物,应在晚上服用。